Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Investigation of low grade glioma tumor immune microenvironment

EF 2022-23

Résumé
Pediatric gliomas are tumors originating from glial cells, in the brain, and can be classified, based on WHO grades, into low grade gliomas (pLGG) and high-grade gliomas (pHGG). LGGs present as less aggressive tumors with a better prognosis while pHGGs are more aggressive and lead to death within a few years. Among the different types of tumors, their microenvironments, meaning the tumor and cells around it, are different and often contribute to the suppression of any normal immune response towards the tumor. The cell types present in the tumor environment and how they contribute to the growth or suppression of the tumor remains unclear for most tumors, specifically pLGGs. With a better understanding the cells involved in the microenvironments, it may be possible to develop more efficient therapies. This would be extremely valuable for pLGGs which are generally treated but may relapse. Through single cell RNA-seq, a technique used to determine the genes a cell is expressing, we can determine the different cell types and better understand the behavior of certain populations, giving a better insight on how these cells are contributing to the tumor microenvironment. Additionally, by using imaging mass cytometry, a sophisticated and powerful imaging technique, we can gain a broad picture of the tumor microenvironment by determining the cells involved as well as the interactions, at the protein level. We can then explore these cell populations closer to understand the mechanisms by which these cells either promote or inhibit the immune response towards the tumor. Finding such markers of disease is therefore a primary objective to better understand the microenvironment of these tumors and find new avenues for therapies for such deadly tumors.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486085
Name
Puligandla Evan
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigation of low grade glioma tumor immune microenvironment
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarker; Cancer; Glioma; Imc; Immune; Immunotherapy; Low-Grade; Microenvironment; Rna-Seq; Tumor
Abstract
Pediatric gliomas are tumors originating from glial cells, in the brain, and can be classified, based on WHO grades, into low grade gliomas (pLGG) and high-grade gliomas (pHGG). LGGs present as less aggressive tumors with a better prognosis while pHGGs are more aggressive and lead to death within a few years. Among the different types of tumors, their microenvironments, meaning the tumor and cells around it, are different and often contribute to the suppression of any normal immune response towards the tumor. The cell types present in the tumor environment and how they contribute to the growth or suppression of the tumor remains unclear for most tumors, specifically pLGGs. With a better understanding the cells involved in the microenvironments, it may be possible to develop more efficient therapies. This would be extremely valuable for pLGGs which are generally treated but may relapse. Through single cell RNA-seq, a technique used to determine the genes a cell is expressing, we can determine the different cell types and better understand the behavior of certain populations, giving a better insight on how these cells are contributing to the tumor microenvironment. Additionally, by using imaging mass cytometry, a sophisticated and powerful imaging technique, we can gain a broad picture of the tumor microenvironment by determining the cells involved as well as the interactions, at the protein level. We can then explore these cell populations closer to understand the mechanisms by which these cells either promote or inhibit the immune response towards the tumor. Finding such markers of disease is therefore a primary objective to better understand the microenvironment of these tumors and find new avenues for therapies for such deadly tumors.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Puligandla, Evan
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~